(Q38389189)

English

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

scientific article published on August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine (English)

1 reference

Europe PubMed Central

2 September 2017

phase III clinical trial

0 references

0 references

Japanese encephalitis virus

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Tauber

1

1 reference

Europe PubMed Central

2 September 2017

H Kollaritsch

2

1 reference

Europe PubMed Central

2 September 2017

F von Sonnenburg

3

1 reference

Europe PubMed Central

2 September 2017

M Lademann

4

1 reference

Europe PubMed Central

2 September 2017

B Jilma

5

1 reference

Europe PubMed Central

2 September 2017

C Firbas

6

1 reference

Europe PubMed Central

2 September 2017

T Jelinek

7

1 reference

Europe PubMed Central

2 September 2017

C Beckett

8

1 reference

Europe PubMed Central

2 September 2017

J Knobloch

9

1 reference

Europe PubMed Central

2 September 2017

W J H McBride

10

1 reference

Europe PubMed Central

2 September 2017

E Schuller

11

1 reference

Europe PubMed Central

2 September 2017

A Kaltenböck

12

1 reference

Europe PubMed Central

2 September 2017

W Sun

13

1 reference

Europe PubMed Central

2 September 2017

A Lyons

14

1 reference

Europe PubMed Central

2 September 2017

language of work or name

0 references

publication date

1 August 2008

1 reference

Europe PubMed Central

2 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

2 September 2017

198

1 reference

Europe PubMed Central

2 September 2017

4

1 reference

Europe PubMed Central

2 September 2017

493-499

1 reference

Europe PubMed Central

2 September 2017

Japanese encephalitis for a reference to international travelers

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Control of Japanese encephalitis--within our grasp?

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Anaphylaxis after vaccination due to hypersensitivity to gelatin

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Case-control study of allergic reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Side-effects with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Adverse reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1086%2F590116

21 January 2018

Identifiers

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38389189&oldid=1757284223"